Predicate Devices: How to Find and Choose One for Your 510(k)

2026-09-16 · Caduvo Team

Selecting the right 510(k) predicate device directly shapes your testing burden and FDA review timeline. Here is how to find, evaluate, and rank candidate predicates.

Engineering teams often celebrate technical novelty, but in medical device regulation, novelty can introduce significant friction. Every technological divergence from an existing commercial comparator demands verification testing, animal models, or human clinical evidence to satisfy Food and Drug Administration (FDA) reviewers. In a premarket notification, anchoring a submission to an inappropriate comparator can trigger extensive Additional Information holds and months of review delay. Securing marketing clearance requires anchoring your device to a defensible benchmark: a strong, legally marketed predicate device.

Demonstrating substantial equivalence is the statutory engine of the 510(k) pathway. To move your submission through the Center for Devices and Radiological Health (CDRH), you must understand how agency reviewers evaluate candidate predicates, how to search FDA databases systematically, and how your predicate choice directly shapes testing burdens.

What Is a Predicate Device Under 21 CFR 807

To clear a device through the premarket notification program, an applicant must demonstrate substantial equivalence to a legally marketed comparator. Under section 513(i)(1)(A) of the Federal Food, Drug, and Cosmetic (FD&C) Act, substantial equivalence requires that the new device has the same intended use as the predicate, and either has the same technological characteristics or has different technological characteristics that do not raise different questions of safety and effectiveness.

When evaluating what is a predicate device under agency policy, regulatory teams must operate within the statutory categories established by Congress and CDRH. The Medical Device Amendments of 1976 gave FDA authority to oversee medical devices and created the three-class risk structure. In 1990, the Safe Medical Devices Act codified the substantial equivalence review standard. According to FDA training materials on the 510(k) review process, which accounts for over 3,000 submissions annually, a legally marketed predicate must fall into one of four distinct categories:

  1. A preamendments device legally marketed in the United States prior to May 28, 1976, that has not been significantly changed or modified, and for which FDA has not published a regulation requiring a Premarket Approval (PMA) application.
  2. A postamendments device cleared through the 510(k) pathway.
  3. A device originally on the U.S. market as a Class III device that the FDA subsequently reclassified to Class II or Class I.
  4. A device authorized for commercial distribution through a granted De Novo classification order.

While preamendments devices remain legally valid comparators, CDRH strongly discourages relying on them. Under FDA guidance on how to find and effectively use predicate devices, preamendments devices do not possess a 510(k) number because they were grandfathered from review. To use one, an applicant must document that the device was labeled, promoted, and distributed in interstate commerce for that specific intended use before May 28, 1976. Because testing methodologies have advanced since 1976, FDA explicitly recommends selecting a device recently cleared under 510(k) as your predicate.

Submissions must satisfy the regulatory content requirements codified in 21 CFR 807.87 within 21 CFR 807 Subpart E. Since October 1, 2023, all 510(k) submissions, unless exempted, must be submitted electronically through the CDRH Portal using the electronic Submission Template And Resource (eSTAR). There is no standard application form, but the eSTAR structure requires a line-by-line comparison establishing equivalence in intended use, materials, design, energy characteristics, and performance standards. Additionally, FDA assesses user fees for reviewing 510(k) notifications, making predicate selection a financial commitment as well as a regulatory one.

Systematic Database Search Workflow for Candidate Predicates

Identifying a legally compliant predicate device requires analyzing cleared regulatory documentation rather than marketing brochures. Commercial materials highlight branding and clinical benefits, whereas FDA reviewers evaluate clearance based on intended use and technical attributes described in public summaries.

Regulatory teams can execute a structured four-step search workflow across CDRH databases:

Step 1: Identify the Classification Regulation and FDA Product Code

Begin by determining the classification regulation in Title 21 of the Code of Federal Regulations and the corresponding FDA product code. Review the limitations of exemptions under the relevant CFR chapters, such as 21 CFR 862.9 or 21 CFR 864.9, to confirm that a 510(k) is legally required. The classification regulation establishes whether the device falls into Class I, Class II, or Class III, and defines the general regulatory controls that apply.

Step 2: Query the Public 510(k) Database

Filter the FDA 510(k) database using your identified product code. Sort the output by clearance date, prioritizing recently cleared devices over older clearances. Download the publicly available 510(k) summaries for each candidate. As explained in NIH guidance on 510(k) pre-submission meetings, these summaries provide the indications for use (IFU) statements, device descriptions, and summaries of performance testing used to establish equivalence.

Step 3: Trace the Comparator Lineage

Review the predicate devices cited within your candidate's 510(k) summary. Medical technologies often follow an evolutionary chain where Device C cleared against Device B, which originally cleared against Device A. Tracing this lineage illustrates which design variations required non-clinical bench protocols and whether previous applicants were required to submit animal data or clinical performance studies.

Step 4: Confirm Market and Legal Standing

Under FDA policy, an applicant may claim substantial equivalence to a device that is no longer commercially marketed in the United States, provided that the comparator was not removed from the market in violation of the FD&C Act. However, selecting a discontinued device eliminates the option of purchasing commercial samples off the shelf for comparative bench testing.

Regulatory and commercial teams can use Caduvo to evaluate regulatory classification pathways and examine cleared comparator profiles before finalizing submission plans.

Ranking Predicate Candidates: 4 Objective Decision Rules

Once you identify several candidates sharing your product code, rank them based on regulatory risk. In draft guidance Docket Number FDA-2023-D-3134, Best Practices for Selecting a Predicate Device, CDRH and CBER outlined recommendations to modernize comparator selection.

Use these four criteria to evaluate candidate devices:

1. Match the Scope of Indications for Use

Substantial equivalence requires having the same intended use. According to NIH guidance, the intended use describes the general therapeutic or diagnostic purpose or function of the device. The indications for use describe how, when, where, and under what conditions the device is used. If your candidate predicate has a broad general surgical indication but your labeling specifies a targeted pediatric or cardiovascular indication, the FDA may determine that the difference raises new questions of safety and effectiveness, leading to a Not Substantially Equivalent (NSE) outcome.

2. Screen for Recalls and Unmitigated Safety Signals

Under FDA's best-practice recommendations, applicants should prioritize predicates that meet or exceed expected safety and performance, are without unmitigated use-related or design-related safety issues, and have not been subject to a design-related recall. Citing a predicate that was recalled for a design defect invites CDRH reviewers to request testing showing that your device does not exhibit the same failure mechanism.

3. Evaluate Testing Methodologies and Standards

FDA recommends selecting a predicate device that was cleared using well-established testing methods. Substantial equivalence is established across design, materials, energy delivered, biocompatibility, and recognized consensus standards. If a candidate cleared decades ago under obsolete testing protocols, your submission must still meet current FDA-recognized standards. Selecting a recently cleared predicate ensures that the performance testing documented in its 510(k) summary aligns with current agency testing expectations.

4. Benchmark the Performance Testing Burden

Examine the performance data section of each candidate's 510(k) summary. If Candidate 1 gained clearance using standard bench performance testing and biocompatibility assessments, while Candidate 2 required human clinical trials to demonstrate equivalence, Candidate 1 represents a lower-burden benchmark—provided your technological characteristics align with it.

Primary Predicates and the Risks of Multiple Comparators

In guidance on how to prepare a traditional 510(k), FDA states that applicants should identify a primary predicate device that is most similar to the submission with respect to indications for use and technological characteristics.

While FDA guidance acknowledges that an applicant may claim substantial equivalence to more than one predicate under certain circumstances, doing so complicates review. As noted in NIH pre-submission guidance, selecting a single predicate device simplifies and facilitates the agency's decision-making process.

Attempting a split predicate strategy—relying on Device X for indications for use and Device Y for core technological characteristics—frequently stalls review. The 510(k) decision-making flowchart used by CDRH staff requires that the primary predicate share the same intended use. When an applicant splits critical claims between distinct devices, reviewers must evaluate whether the combined features introduce different questions of safety and effectiveness that require new validation models.

When a candidate predicate differs in technological characteristics, those differences must not alter the intended use or introduce unresolved safety questions. If no legally marketed device shares your intended purpose and technological profile, the 510(k) pathway is likely inapplicable. In such cases, evaluate whether the device requires the De Novo classification pathway or a Premarket Approval (PMA) application instead.

Actionable Predicate Selection Checklist

Before locking your device design freeze or finalizing eSTAR documentation, execute this practical review sequence:

  1. Query the product code: Search the CDRH 510(k) database using your device classification regulation and product code to compile all cleared comparators.
  2. Prioritize recent clearances: Screen for predicates cleared under modern review standards, avoiding preamendments devices that lack a 510(k) number.
  3. Audit safety history: Verify under Docket Number FDA-2023-D-3134 that candidate devices have no design-related recalls or unmitigated safety issues.
  4. Designate a single primary predicate: Select one primary device that mirrors your intended use and technological profile, avoiding split-predicate dependencies.
  5. Request a Pre-Submission when in doubt: Submit a formal pre-submission meeting request to obtain FDA feedback on your proposed predicate rationale and planned non-clinical testing protocols before running full-scale verification studies.

Sources

  1. How to Find and Effectively Use Predicate Devices | FDA
  2. How to Prepare a Traditional 510(k) | FDA
  3. Best Practices for Selecting a Predicate Device to Support a Premarket Notification [510(k)] Submission | FDA
  4. https://seed.nih.gov/sites/default/files/2023-10/510k-Pre-Submission-Meetings.pdf
  5. Premarket Notification 510(k) | FDA
  6. Overview of the 510(k) Process: Guide for Third Party Reviewers

General information, not regulatory, legal or reimbursement advice. Company and product names belong to their owners; a mention does not imply affiliation or endorsement. Report an error. Data and corrections policy.

Related reading